Cost‐Effectiveness Analysis of Introduction of Rapid, Alternative Methods to Identify Multidrug‐Resistant Tuberculosis in Middle‐Income Countries-Reference-Cited by-同舟云学术

Cost‐Effectiveness Analysis of Introduction of Rapid, Alternative Methods to Identify Multidrug‐Resistant Tuberculosis in Middle‐Income Countries

Published:2008-08-15 Issue:4 Volume:47 Page:487-495
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:CLIN INFECT DIS

Author:

Acuna‐Villaorduna Carlos,Vassall Anna,Henostroza German,Seas Carlos,Guerra Humberto,Vasquez Lucy,Morcillo Nora,Saravia Juan,O’Brien Richard,Perkins Mark D.,Cunningham Jane,Llanos‐Zavalaga Luis,Gotuzzo Eduardo

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/47/4/487/858896/47-4-487.pdf

Reference45 articles.

1. Global Surveillance for Antituberculosis-Drug Resistance, 1994–1997

2. Global Trends in Resistance to Antituberculosis Drugs

3. Treatment of 171 Patients with Pulmonary Tuberculosis Resistant to Isoniazid and Rifampin

4. Treatment Experience of Multidrug-Resistant Tuberculosis in Florida, 1994–1997

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rethinking Tuberculosis Morbidity Quantification: A Systematic Review and Critical Appraisal of TB Disability Weights in Cost-Effectiveness Analyses;PharmacoEconomics;2024-08-07

2. Health system productivity in sub-Saharan Africa: tuberculosis control in high burden countries;Cost Effectiveness and Resource Allocation;2023-11-25

3. Cost Analysis for Patients with Presumed Pulmonary Tuberculosis Attended in the Public Health System of Rio de Janeiro, Brazil;The International Journal of Mycobacteriology;2021-04

4. Detection of low-frequency resistance-mediating SNPs in next-generation sequencing data of Mycobacterium tuberculosis complex strains with binoSNP;Scientific Reports;2020-05-12

5. A Systematic Review of Methodological Variation in Healthcare Provider Perspective Tuberculosis Costing Papers Conducted in Low- and Middle-Income Settings, Using An Intervention-Standardised Unit Cost Typology;PharmacoEconomics;2020-05-04